Medtronic plc buy Royal Bank of Canada
Start price
19.02.25
/
50%
€82.68
Target price
19.02.26
€100.70
Performance (%)
5.94%
Price
30.01.26
€86.89
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada shows slight gains of 5.94%. Dividends of €0.70 are taken into consideration when calculating the performance. This prediction currently runs until 19.02.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Medtronic plc | 1.804% | 1.804% |
| iShares Core DAX® | -1.432% | 0.000% |
| iShares Nasdaq 100 | -0.386% | -0.595% |
| iShares Nikkei 225® | 1.448% | 5.269% |
| iShares S&P 500 | 0.114% | -0.217% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Medtronic plc diskutieren
Medtronic plc (NYSE: MDT) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $105.00 price target on the stock.
Ratings data for MDT provided by MarketBeat